| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |